CLBT vs NVDA

For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.

5% revenue growth year-over-year, versus 18. 6% for Cellebrite DI Ltd. (CLBT). NVIDIA Corporation (NVDA) offers the better valuation at 43. 2x trailing P/E (25. 6x forward), making it the more compelling value choice. Analysts rate Cellebrite DI Ltd. (CLBT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 43.

2x versus Cellebrite DI Ltd. at 44. 5x. On forward P/E, NVIDIA Corporation is actually cheaper at 25. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 27x versus Cellebrite DI Ltd. 's 0. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1329%, compared to +39.

9% for Cellebrite DI Ltd. (CLBT). Over 10 years, the gap is even starker: NVDA returned +239. 0% versus CLBT's +43. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cellebrite DI Ltd.

(CLBT) is the lower-risk stock at 0. 76β versus NVIDIA Corporation's 1. 73β — meaning NVDA is approximately 126% more volatile than CLBT relative to the S&P 500. On balance sheet safety, Cellebrite DI Ltd. (CLBT) carries a lower debt/equity ratio of 5% versus 7% for NVIDIA Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.

5% versus 18. 6% for Cellebrite DI Ltd. (CLBT). On earnings-per-share growth, the picture is similar: Cellebrite DI Ltd. grew EPS 123. 0% year-over-year, compared to 66. 7% for NVIDIA Corporation. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

NVIDIA Corporation (NVDA) is the more profitable company, earning 55.

6% net margin versus 16. 5% for Cellebrite DI Ltd. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus 14. 0% for CLBT. At the gross margin level — before operating expenses — CLBT leads at 84. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 27x versus Cellebrite DI Ltd. 's 0. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 25. 6x forward P/E versus 37. 5x for Cellebrite DI Ltd. — 12. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLBT: 49. 7% to $20. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Cellebrite DI Ltd.

(CLBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76)). NVIDIA Corporation (NVDA) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLBT: +43. 0%, NVDA: +239. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.